Fifth Third Bancorp’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Fifth Third Bancorp’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-33	Closed	-$1K	–	3032
2015 Q3	$1K	Buy	+33	New	+$1.39K	﹤0.01%	2866
2015 Q2	–	Sell	-15,454	Closed	-$599K	–	2991
2015 Q1	$599K	Buy	15,454 +4,653	+43%	+$179K	0.01%	704
2014 Q4	$364K	Buy	+10,801	New	+$381K	﹤0.01%	815
2014 Q3	–	Sell	-157	Closed	-$5K	–	2555
2014 Q2	$5K	Sell	157 -207	-57%	-$7.08K	﹤0.01%	2180
2014 Q1	$13K	Buy	+364	New	+$13.4K	﹤0.01%	1932

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Fifth Third Bancorp's WX Position: Q4 2015 in Review

Fifth Third Bancorp sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 33 shares — an estimated $1K sold.

Fifth Third Bancorp first reported a position in WX in Q1 2014 and held it in 5 quarters. The position peaked at $599K in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Fifth Third Bancorp reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Fifth Third Bancorp sold 33 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1K.
Fifth Third Bancorp first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 5 quarters.
Fifth Third Bancorp's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $599K in Q1 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Fifth Third Bancorp's 13F filing for Q4 2015, filed 16 Feb 2016.